We are live on
!
Find out more
WCM
Weld Capital Management Portfolio holdings
AUM
$98.8M
1-Year Est. Return
52.83%
This Fund
S&P 500
This Quarter
Est. Return
+31.95%
1 Year Est. Return
+52.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$58.8M
(+30%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
10.69%
Top 10 Holdings %
Top 10 Hldgs %
8.39%
Holding
719
New
321
Increased
57
Reduced
70
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.86M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$2.35M |
| 3 |
Voya Financial
VOYA
|
+$2.1M |
| 4 |
Idacorp
IDA
|
+$2.03M |
| 5 |
Cardinal Health
CAH
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.11M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$1.99M |
| 3 |
Lam Research
LRCX
|
+$1.92M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.84M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.35% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Technology | 12.47% |
| 4 | Financials | 12.13% |
| 5 | Industrials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
201
DELISTED
Noble Energy, Inc.
NBL
| $455K | 0.18% |
+50,818
| New | +$454K |
|
|
ESPR
202
DELISTED
Esperion Therapeutics
ESPR
| $448K | 0.18% |
+8,733
| New | +$365K |
|
203
Mid-America Apartment Communities
MAA
$16B
| $448K | 0.18% |
+3,908
| New | +$440K |
|
204
Teva Pharmaceuticals
TEVA
$40.4B
| $447K | 0.18% |
+36,257
| New | +$410K |
|
205
Plug Power
PLUG
$2.65B
| $445K | 0.17% |
+54,158
| New | +$254K |
|
206
Moog Inc Class A
MOG.A
$12.4B
| $443K | 0.17% |
+8,360
| New | +$429K |
|
207
Mettler-Toledo International
MTD
$28.1B
| $441K | 0.17% |
+547
| New | +$407K |
|
|
HIBB
208
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $441K | 0.17% |
21,069
+2,598
| +14% | +$43.3K |
|
|
BHVN
209
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $441K | 0.17% |
+6,037
| New | +$321K |
|
210
Burlington
BURL
$23.4B
| $438K | 0.17% |
+2,222
| New | +$419K |
|
211
Waste Management
WM
$95B
| $434K | 0.17% |
+4,099
| New | +$414K |
|
212
SolarEdge
SEDG
$2.37B
| $427K | 0.17% |
+3,075
| New | +$376K |
|
213
JPMorgan Chase
JPM
$916B
| $419K | 0.16% |
+4,459
| New | +$423K |
|
214
Gilead Sciences
GILD
$165B
| $412K | 0.16% |
5,351
-4,763
| -47% | -$365K |
|
|
QVCGA
215
DELISTED
QVC Group Inc Series A
QVCGA
| $401K | 0.16% |
869
-728
| -46% | -$284K |
|
|
TTM
216
DELISTED
Tata Motors Limited
TTM
| $393K | 0.15% |
59,879
+45,340
| +312% | +$261K |
|
217
Tenable Holdings
TENB
$3.47B
| $386K | 0.15% |
+12,957
| New | +$352K |
|
218
BlackBerry
BB
$4.58B
| $380K | 0.15% |
+77,635
| New | +$351K |
|
219
Sanmina
SANM
$8.78B
| $378K | 0.15% |
+15,092
| New | +$397K |
|
220
Malibu Boats
MBUU
$548M
| $374K | 0.15% |
7,200
-118
| -2% | -$4.71K |
|
221
Kohl's
KSS
$2.16B
| $373K | 0.15% |
+17,968
| New | +$346K |
|
222
MarketAxess Holdings
MKTX
$4.47B
| $371K | 0.15% |
+741
| New | +$345K |
|
|
GBT
223
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $370K | 0.15% |
+5,859
| New | +$402K |
|
224
Allison Transmission
ALSN
$9.51B
| $369K | 0.14% |
10,035
+2,613
| +35% | +$93.6K |
|
225
Workday
WDAY
$41.5B
| $369K | 0.14% |
1,972
-5,472
| -74% | -$885K |
|
Similar funds
BCM
CCM
RGM
RC
TCM
AC
QVT
WFWM
Weld Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Weld Capital Management held 719 positions worth $255M, up 30% from $196M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Weld Capital Management deployed $27.3M of net new capital in Q2 2020, opening 321 new positions and adding to 57 existing holdings. Its largest new stake was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Lam Research, an estimated $1.92M trimmed.
- Weld Capital Management's largest Q2 2020 buy was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
- Weld Capital Management added most to GoDaddy in Q2 2020, an estimated $1.61M increase.
- Weld Capital Management's biggest Q2 2020 reduction was Lam Research, cutting an estimated $1.92M.
- Weld Capital Management fully exited Vertex Pharmaceuticals in Q2 2020, selling an estimated $2.11M.
- Weld Capital Management's ten largest holdings make up 8.4% of its $255M portfolio in Q2 2020.
- Weld Capital Management opened 321 new positions and closed 271 in Q2 2020.
- Weld Capital Management's portfolio value rose 30% quarter-over-quarter to $255M.
Based on Weld Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.